Início do conteúdo
Página Inicial (Inglês)
A Fiocruz’s study to be published in the EID journal (CDC/US) shows that a first exposure to COVID-19 may not produce an immune response
On April 14 will happen the first PrInt Fiocruz-Capes virtual seminar in 2021, with transmission on YouTube
In addiction to the Oxford/AstraZeneca-Fiocruz, the Foundation is developing six other projects leading to new immunizers
Country is facing the collapse of the health system and, at the same time, the pandemic is now taking up new shapes
- Project by Fiocruz Pernambuco on antivirals against Covid-19 is selected in public call
- Fiocruz Amazon confirms reinfection by a new variation of the Sars-CoV-2
- Fiocruz is designated as a WHO Collaborating Center to strengthen Human Milk Banks
- Fiocruz Genomics Network detects novel alterations in the Sars-CoV-2 Spike protein in Brazil
- Fiocruz advances in the management, sharing and opening of data for research
- The United Kingdom Embassy and Fiocruz strengthen their cooperation for a vaccine
- Fiocruz specialist is considered the greatest specialist in cutaneous leishmaniasis
- Fiocruz opens a virtual exhibit: “Zika: affecting lives”
- COVID-19 Observatory points to the biggest health system collapse in the history of Brazil
- Brazil faces the worst scenario since the beginning of the pandemic
- Fiocruz receives first registration for a Covid-19 vaccine produced in Brazil
- COVID-19 Observatory warns for a critical health situation in Brazil
- Fiocruz president participates in a WHO meeting on therapeutics for Covid-19
- BRICS and the global vaccine barbarism
- Fiocruz identifies a mutation associated to worrying variants in Brazil
Photos are part of the historical files of Fiocruz, that keep text documents, maps, films and tapes
See the time line of the most representative events about Covid-19 at Fiocruz
The newsletter of the Fiocruz Global Health Center highlights the latest news about researches, international agreements, courses and more.
Fiocruz is one of the leading institutions on Zika's research. See here some of the newest findings on the theme
Subscribe to Fiocruz International Newsletter
Subscribe and receive our news via email
Fiocruz nas redes sociais
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
